PI-RADS 第2版与第2.1版对前列腺移行区前列腺癌检出能力的比较
回顾性纳入58例PSA升高患者,行3T多参数前列腺MRI(含T2WI与DWI)及MRI-经直肠超声融合靶向穿刺活检,以活检病理为参考标准,比较PI-RADS v2与v2.1对移行区前列腺癌的诊断效能。v2.1的观察者间一致性略高(κ 0.645 vs 0.580),两版本敏感度无差异,阅片者1特异度v2.1更高(p=0.002),AUC有升高趋势但差异未达统计学显著。
要点
- 移行区病灶评估中,PI-RADS v2.1的观察者间一致性κ为0.645,v2为0.580。
- 两版本诊断敏感度无差异(p≥0.500);阅片者1特异度v2.1更高(p=0.002),阅片者2两版本相似(p=1.000)。
- AUC在v2.1有升高趋势但差异未达统计学显著:阅片者1 0.786 vs 0.847(p=0.052),阅片者2 0.808 vs 0.858(p=0.197)。
诊断标准与关键数值
- 按PI-RADS v2与v2.1分别对每个移行区病灶的T2WI(1-5分)、DWI(1-5分)及总体PI-RADS评估分类进行评分。
- 观察者间一致性κ:v2为0.580,v2.1为0.645。
- 诊断敏感度两版本无差异(p≥0.500);阅片者1特异度v2.1更高(p=0.002),阅片者2两版本相似(p=1.000)。
- AUC:阅片者1 v2为0.786 vs v2.1为0.847(p=0.052);阅片者2 v2为0.808 vs v2.1为0.858(p=0.197),差异均未达统计学显著。
临床应用与阅片要点
- 作者认为,与PI-RADS v2相比,PI-RADS v2.1可能更适合用于评估前列腺移行区病灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the diagnostic performance of PI-RADS v2 and v2.1 for detecting transition zone prostate cancer (TZPC) on multiparametric prostate MRI (mpMRI).
METHOD: Fifty-eight patients with elevated PSA levels underwent mpMRI at 3 T including T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), and subsequent MRI-transrectal ultrasonography fusion-guided prostate-targeted biopsy (MRGB). The standard of reference was MRGB-derived histopathology. Two readers independently assessed each TZ lesion, assigning a score of 1-5 for T2WI, a score of 1-5 for DWI, and the overall PI-RADS assessment category according to PI-RADS v2 and v2.1. The diagnostic performance of the two methods was compared in terms of inter-reader agreement, diagnostic sensitivity, diagnostic specificity, and area under the ROC curve (AUC).
RESULTS: Of the 58 patients, 26 were diagnosed with PC (GS = 3 + 3, n = 9; GS = 3 + 4, n = 9; GS = 3 + 5, n = 1; GS = 4 + 3, n = 4; GS = 4 + 4, n = 3) and 32 with benign lesions. Regarding inter-reader agreement of overall PI-RADS assessment category, the kappa value was 0.580 for v2 and 0.645 for v2.1. For both readers, there was no difference in diagnostic sensitivity between the versions (p ≥ 0.500). For reader 1, the diagnostic specificity was higher for v2.1 (p = 0.002), and was similar for reader 2 (p = 1.000). For both readers, AUC tended to be higher for v2.1 than for v2, but the difference was not significant (0.786 vs. 0.847 for reader 1, p = 0.052; and 0.808 vs. 0.858 for reader 2, p = 0.197).
CONCLUSIONS: These results suggest that compared with PI-RADS v2, PI-RADS v2.1 could be preferable for evaluating TZ lesions.
引用
- Tamada T, Kido A, Takeuchi M, et al. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer. Eur J Radiol. 2019. PMID: 31669798. doi:10.1016/j.ejrad.2019.108704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。